Discussion of urine addictive drugs Screening in clinical trials
10.13699/j.cnki.1001-6821.2018.03.056
- VernacularTitle:临床试验尿液成瘾药物筛查探讨
- Author:
Xiong-Fei LIU
1
;
Jun-Yu XU
;
Xia ZHAO
;
Ying ZHOU
;
Yi-Ming CUI
Author Information
1. 北京大学第一医院药剂科
- Keywords:
clinical trial;
addictive drug;
adverse drug reaction;
drug interaction
- From:
The Chinese Journal of Clinical Pharmacology
2018;34(3):371-374
- CountryChina
- Language:Chinese
-
Abstract:
Urine addictive drugs screening is one of the key operations for drug I phase clinical trials and bioequivalence tests in subject recruitment;It is also one of the necessary measures to ensure the safety of subjects and the accuracy and reliability of clinical trial results.However,the current clinical trial guidelines do not clearly indicate the significance of Urine drug screening in clinical trials.This article is based on screening of addictive drugs in the Peking university first hospital I phase clinical trial Unit in recent years,to illustrate the necessity of drug screening in clinical trials.
